Search the Newsreel

UBS Group Has Lowered Expectations for Cogent Communications (NASDAQ:CCOI) Stock Price

Enterprise value to EBITDA forward of Agency Group Australia Ltd – ASX:AU1

American Century group reports 5.4% Emergent BioSolutions (EBS) ownership on Schedule 13G

American Century ETF Trust and its affiliates, including American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research, have reported passive ownership stakes in Emergent BioSolutions Inc. (EBS) common stock via a Schedule 13G filing. The ETF Trust …

General Motors (NYSE:GM) Declares Dividend As Capital Discipline Takes Center Stage

General Motors has declared a cash dividend, signaling confidence in its financial health and a commitment to capital discipline. The company is focusing on higher-margin vehicles like trucks and large SUVs to fund its electric vehicle transition while carefully managing spending. This strategy aims …

Gentex (GNTX): American Century group discloses 5.2% beneficial ownership stake

American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research have collectively reported a 5.2% beneficial ownership stake in Gentex Corporation (GNTX). This group owns 11,025,677 shares of Gentex common stock as of June 30, 2026, holding sole …

Bionano Genomics (BNGO) investor discloses 9.9% position via warrants

CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a 9.9% beneficial ownership in Bionano Genomics (BNGO) through warrants. This position, amounting to 1,307,135 shares, is subject to ownership caps of 4.99% and 9.99% for different portions of the warrants. The ownership percentage …

NexGen Energy: Construction Turns Regulatory Scarcity Into A Uranium Moat (NYSE:NXE)

NexGen Energy has begun major construction on its Rook I uranium project after securing final federal approval, positioning itself as a crucial Western uranium supplier. The company's competitive advantage lies in its timely progress, as other projects face permitting delays, and its strong liquidity …

Loma Negra (LOMA) Q2 2026 Earnings Call Transcript

Loma Negra (LOMA) reported Q2 2026 results showing a 2.1% increase in consolidated net revenue despite a 1.4% decrease in cement sales volume, primarily due to heavy rains in April. Consolidated Adjusted EBITDA declined by 2.5% year over year, reflecting higher costs and depreciation. …

Genmab A/S (GMAB): Orbis and Allan Gray report 5.3% beneficial ownership stake

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly reported a beneficial ownership stake of 5.3% in Genmab A/S (GMAB), totaling 3,328,505 Ordinary Shares. This includes both direct Ordinary Shares and American Depositary Shares (ADS). The filing indicates that while they …

Vistagen (VTGN) narrows quarterly loss, eyes FDA path after mixed fasedienol data

Vistagen (VTGN) reported a narrower net loss of $13.0 million for Q1 FY2027, an improvement from $15.1 million in the prior-year quarter, largely due to increased revenue and reduced R&D and G&A expenses. While its lead drug fasedienol missed its primary endpoint in the …

VistaGen Therapeutics earnings missed by $0.05, revenue topped estimates

Vistagen Therapeutics Releases Q1 2027 Financial Results

Vistagen Therapeutics reported a narrower loss for Q1 fiscal 2027, with a basic and diluted loss of $0.30 per share and a net loss of $13.0M. The company saw a significant revenue increase to $1.5M, up 504.9% year-over-year, as it continues to develop therapies …

Volkswagen (XTRA:VOW3) Could Be 31% Below Fair Value After US Push Reports

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Volkswagen (XTRA:VOW3) is back in focus after reports it will appoint outgoing Audi sales chief Marco Schubert to lead its US business, with a fresh push into …

HSBC Stock And 2 Global Bank Picks for Trade and Rate Rule Changes

This article identifies three global banking stocks—Banco Bilbao Vizcaya Argentaria (BBVA), Banco Santander (SAN), and HSBC Holdings (HSBA)—that are well-positioned to navigate the evolving landscape of trade, interest rates, and compliance regulations. These banks offer diversified operations, significant digital banking investments, and varying risk-reward …

Highbridge Capital (AXIN) discloses 9.1% holding in Axiom Intelligence Class A

Cathay General Bancorp (CATY) Could Be Fully Valued After Fresh Growth And Capital Concerns

New analysis suggests Cathay General Bancorp (CATY) may be fully valued despite a recent share price surge and a narrative of being "30% undervalued" by analysts. Concerns include lagging net interest income, earnings growth, and expectations for soft capital generation. The bank's reliance on …

Vistagen Reports Narrower Q1 Loss; Plans FDA Meeting On Fasedienol Development Path

(RTTNews) - Vistagen Therapeutics Inc. (VTGN), a late clinical-stage biopharmaceutical company developing intranasal pherine therapies for neuropsychiatric and other disorders, reported first quarter fiscal 2027 results and provided a corporate update. Vistagen is developing rapid-onset intranasal pherine product candidates designed to target nose-to-brain neurocircuitry. …

Are You Looking for a Top Momentum Pick? Why Urogen Pharma (URGN) is a Great Choice

Urogen Pharma (URGN) is highlighted as a strong momentum pick due to its "A" Momentum Style Score from Zacks and a Zacks Rank of #2 (Buy). The article details URGN's impressive short-term and long-term price performance, outperforming both its industry and the S&P 500. …

Why Is General Motors Resuming EV Battery Production in Ohio?

General Motors is set to restart battery cell production at its Ultium Cells facility in Warren, Ohio, after a seven-month shutdown due to weaker EV demand. This joint venture with LG Energy Solution will resume operations next week with an expected 1,400 employees, producing …

GenSight Biologics S.A.: Objectif de Cours et Consensus des Analystes | SIGHT | FR0013183985

argenx SE: Objectif de Cours et Consensus des Analystes | ARGX | NL0010832176

Genesis Energy Q2 Net Income Rises to $42.9 Million

Genesis Energy reported a significant increase in its second-quarter net income, rising to $42.9 million from $10.1 million in the prior-year period. This growth was primarily driven by higher operating income across all its segments. Despite the strong performance, the company announced that its …

Argenx stock steadies after Forte Biosciences deal and post-earnings pullback

Argenx stock is consolidating after a strong Q2 2026 earnings beat and a significant $2.2 billion acquisition of Forte Biosciences. Despite a recent pullback, the stock remains in positive territory year-to-date, with analysts maintaining a constructive outlook and an implied upside of roughly 23% …

General Fusion Group Ltd. Cl A (NASDAQ: GFUZ) Stock Price, News & Analysis

This page provides an overview of General Fusion Group Ltd. Cl A (NASDAQ: GFUZ) stock, including its current price, basic financial fundamentals, and a chart from TradingView. It also offers access to various Kalkine research reports and tools. The article highlights the stock's performance …

Armistice Capital (MGNX) discloses 5.0M-share MacroGenics position in 13G/A

Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 5,006,752 shares of MacroGenics, Inc. common stock, which represents 7.88% of the outstanding class. Both Armistice Capital, as investment manager, and Steven Boyd, as its managing member, hold shared voting and dispositive …

GENESYS: Q1 FY27 saw revenue growth, new leadership, and a major Rights Issue announcement

GrowGeneration Beats on Q2 Earnings, Hikes '26 Adjusted EBITDA View

GrowGeneration (GRWG) reported a narrower Q2 2026 loss of 3 cents per share, surpassing the Zacks Consensus Estimate. The company also saw a 5.5% year-over-year sales increase to $43.2 million and raised its full-year adjusted EBITDA outlook to $2-$3 million. This positive performance was …

Repligen Corp (RGEN) stake at 3.1% in new T. Rowe Price 13G/A

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G/A, reporting a 3.1% beneficial ownership stake in Repligen Corp (RGEN), totaling 1,751,887 shares of common stock as of June 30, 2026. The filing indicates sole voting power over 1,744,549 shares and sole dispositive …

10x Genomics (TXG) Q2 2026 Earnings Call Transcript

Analysts Offer Insights on Materials Companies: Franco-Nevada (FNV) and Lithium Argentina (LAR)

Genie Energy Earnings Jump Y/Y in Q2 on Margin Expansion

Intelligent Bio Solutions (INBS) gets 5.91% ownership update from Armistice Capital

Armistice Capital, LLC and Steven Boyd have filed an amended passive ownership report for Intelligent Bio Solutions Inc. (INBS), disclosing a beneficial ownership of 141,397 shares, which represents 5.91% of the common stock. All shares are held with shared voting and dispositive power. Armistice …

Armistice Capital (EVGN) discloses 4.99% beneficial stake in Evogene shares

Armistice Capital, LLC and Steven Boyd have reported a 4.99% beneficial ownership stake in Evogene Ltd. (EVGN) through an amended Schedule 13G filing. This amounts to 713,539 ordinary shares, which are directly held by Armistice Capital Master Fund Ltd. The filing clarifies that Armistice …

Dow Movers: AMGN, HONIV

In early trading on Friday, shares of Honeywell International topped the list of the day's best performing Dow Jones Industrial Average components, trading up 7.5%. Year to date, Honeywell International registers a 42.2% gain. And the worst performing Dow component thus far on the …

Wall Street Analysts Believe Generac Holdings (GNRC) Could Rally 31.51%: Here's is How to Trade

Generac Holdings (GNRC) closed the last trading session at $216.66, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …

Allogene Therapeutics (ALLO) Income Statement & Earnings